Certara Stock (NASDAQ: CERT) stock price, news, charts, stock research, profile.
Open | $17.120 |
Close | $17.000 |
Volume / Avg. | 437.091K / 539.800K |
Day Range | 16.580 - 17.260 |
52 Wk Range | 11.810 - 22.650 |
Market Cap | $2.734B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 48 |
Short Interest | 4.72% |
Days to Cover | 9.32 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Certara (NASDAQ: CERT) through any online brokerage.
Other companies in Certara’s space includes: MultiPlan (NYSE:MPLN), OptimizeRx (NASDAQ:OPRX), GoodRx Holdings (NASDAQ:GDRX), Definitive Healthcare (NASDAQ:DH) and TruBridge (NASDAQ:TBRG).
The latest price target for Certara (NASDAQ: CERT) was reported by Keybanc on Wednesday, April 10, 2024. The analyst firm set a price target for 23.00 expecting CERT to rise to within 12 months (a possible 35.29% upside). 16 analyst firms have reported ratings in the last year.
The stock price for Certara (NASDAQ: CERT) is $17 last updated May 10, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Certara.
Certara’s Q2 earnings are confirmed for Wednesday, August 7, 2024.
There is no upcoming split for Certara.
Certara is in the Health Care sector and Health Care Technology industry. They are listed on the NASDAQ.